DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
PEDIATRIC TREATMENT PROTOCOL S-167
RESPIRATORY DISTRESS
Date: 7/1/2025 Page 1 of 1
BLS ALS
• Ensure patent airway
• Reassurance
• Dislodge any airway obstruction. Treat per
Airway Obstruction Protocol (S-160).
• O2 saturation
• O2 and/or ventilate PRN
• Transport in position of comfort
• Carboxyhemoglobin monitor PRN, if available
• May assist patient to self-medicate own
prescribed albuterol MDI once only. BH
contact required for additional dose(s).
Toxic inhalation (e.g., CO exposure, smoke,
gas)
• Move patient to safe environment
• 100% O2 via mask
• Consider transport to facility with hyperbaric
chamber for suspected CO poisoning for
unconscious or pregnant patients
Croup-like cough
• Aerosolized saline or water 5 mL via O2-
powered nebulizer/mask, MR PRN
Suspected bronchiolitis (<2 years old with no
prior albuterol use)
• Place in position of comfort
• Suction nose with bulb syringe PRN
• Monitor/ECG
• Capnography
• IV Ⓐ
• BVM PRN
Respiratory distress with bronchospasm1
• Albuterol/Levalbuterol per drug chart via nebulizer, MR Ⓐ
• Ipratropium bromide per drug chart via nebulizer added to first
dose of albuterol/levalbuterol
Severe respiratory distress/failure or inadequate response to
nebulized treatments consider
• Epinephrine 1:1,000 per drug chart IM, MR x2 q5 min Ⓐ
Respiratory distress with stridor at rest
• Epinephrine 1:1,000 per drug chart (combined with 3 mL
normal saline) via nebulizer, MR x1 Ⓐ
No improvement after epinephrine via nebulizer x2 or
impending respiratory/airway compromise
• Epinephrine 1:1,000 per drug chart IM, MR x2 q5 min Ⓐ
If history suggests epiglottitis, do not visualize airway. Use
calming measures
Note: For respiratory arrest, immediately start BVM ventilation
1 Infection control: If concerned about aerosolized infectious exposure, substitute with MDI, if available

